Predictive value of CHA2DS2-VASc score combining left atrial diameter for risk of stroke in patients with non-valvular atrial fibrillation

doi:10.3969/j.issn.1004-583X.2016.02.015

Abstract

Abstract: Objective To explore the predictive value of CHA₂DS₂-VASc score combined with left atrial diameter for the risk of stroke in patients with non-valvular atrial fibrillation (NVAF).Methods A total of 230 patients with NVAF were selected. CHA₂DS₂-VASc score was calculated for each patient by the clinical history and auxiliary examination. All patients were followed up for one year after discharging from hospital, and the follow-up visit would be finished if patients suffered from stroke or followed up for one year. The patients were divided into stroke group and non-stroke group according to the follow-up results.Results The CHA₂DS₂-VASc score and left atrial diameter in the stroke group were higher than those of non-stroke group. The area under the ROC curve of CHA₂DS₂-VASc score, left atrial diameter and CHA₂DS₂-VASc score combined with left atrial diameter to predict the happening of stroke in patients with NVAF were respectively 0.789,0.753 and 0.835. There were significant difference in area under the ROC curve among CHA₂DS₂-VASc score, left atrial diameter and CHA₂DS₂-VASc score combined with left atrial diameter(P＜0.01).Conclusion The predictive value of CHA₂DS₂-VASc score combined with left atrial diameter is higher for the occurrence of stroke in patients with NVAF.

Key words: stroke, atrial fibrillation, CHA₂DS₂-VASc score, left atrial diameter

CLC Number:

R743

Geng Wei, Zhang Qi, Tian Xiang, Zhang Tongle, Liu Ying, Fu Yongqi, Qi Lei, Zhu Yao, Jin Lili. Predictive value of CHA₂DS₂-VASc score combining left atrial diameter for risk of stroke in patients with non-valvular atrial fibrillation[J]. Clinical Focus, 2016, 31(2): 198-200.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2016.02.015

https://huicui.hebmu.edu.cn/EN/Y2016/V31/I2/198

References

[1] 周自强, 胡大一, 陈捷, 等. 中国心房颤动现状的流行病学研究[J]. 中华内科杂志,2004,43(7): 491-494.
[2] Hanon O, Assayag P, Belmin J, et al. Expert consensus of the French Society of Geriatrics and Gerontology and the French Society of Cardiology on the management of atrial fibrillation in elderly people[J]. Arch Cardiovasc Dis,2013,106(5): 303-323.
[3] January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society[J]. Circulation,2014,130(23): 2071-2104.
[4] 傅德建, 何剑, 张向阳. 非瓣膜性心房颤动血栓形成危险因素的分析[J]. 中国循环杂志,2012,27(4): 282-284.
[5] 木胡牙提, 卢武红, 马依彤, 等. 1041例非瓣膜性心房颤动患者左心房内径的分析[J]. 中国循环杂志,2009,24(5): 364-366.
[6] Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)[J]. Eur Heart J,2010,31(19): 2369-429.
[7] 中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组. 中国急性缺血性脑卒中诊治指南2010[J]. 中华神经科杂志,2010,43(2): 146-153.
[8] 黄从新, 马长生, 杨延宗,等. 心房颤动:目前的认识和治疗建议(二)[J]. 中华心律失常学杂志,2006,10(3): 167-197.
[9] 胡大一, 郭艺芳. 心房颤动抗凝治疗中国专家共识[J]. 心脑血管病防治,2012,51(3): 173-177.
[10] Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society[J]. Europace,2006,8(9): 651-745.
[11] 刘燕, 龚辉. 非瓣膜性心房纤颤CHADS₂评分低中危患者脑卒中危险因素分析[J]. 中国全科医学,2015,(19): 2290-2293,2305.
[12] 付永奇, 田祥, 耿巍,等. CHADS2评分联合红细胞分布宽度预测非瓣膜病心房颤动患者缺血性脑卒中风险的研究[J]. 中国医刊,2015,50(8): 43-46.
[13] 付永奇, 田祥, 李放, 等非瓣膜性心房颤动患者红细胞分布宽度与CHADS₂评分的关系研究[J]. 中国医药指南,2014,12(32): 178-179.
[14] 孙荣艳, 范正俊, 冯云萍,等. CHADS₂评分法规范老年非瓣膜性房颤治疗研究[J]. 中国医学创新,2015,12(5): 107-110.
[15] 马军伟, 马向红, 崔利军, 等. CHADS2及CHA2DS2-VASc评分对非瓣膜性心房颤动患者左心房/左心耳血栓的预测价值[J]. 天津医药,2015,43(3): 304-308.

Predictive value of CHA₂DS₂-VASc score combining left atrial diameter for risk of stroke in patients with non-valvular atrial fibrillation

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Wang Yihan, Qin Xuyan, Han Xuanze, Wang Yingjie, Gao Feifei, Chen Chunhong, Zhang Lingnan, Zhang Fang. Efficacy and safety of rivaroxaban therapy in elderly patients with non-valvular atrial fibrillation who had a HASBLED score≥3 [J]. Clinical Focus, 2024, 39(2): 121-124.
[2]	Xin Yanhong, Lang Guiyan, Chen Ziwei, Wang Dongyu. Value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in predicting cognitive impairment in patients with acute mild ischemic stroke [J]. Clinical Focus, 2023, 38(6): 504-509.
[3]	Zhang Xueqian, Li Yang, Xu Guodong, Lyu Peiyuan. Analysis of demographic, clinical and imaging in patients with acute cerebral infarction caused by patent foramen ovale [J]. Clinical Focus, 2023, 38(6): 500-503.
[4]	Wang Zhen, Yang Xiaoyue, Li Shaojie, Wang Xian, Chen Shuxia, Gu Jian. Analysis of clinical characteristics and readmission risk factors in patients with ejection fraction preserved heart failure combined with atrial fibrillation [J]. Clinical Focus, 2023, 38(4): 308-314.
[5]	He Xiangyu, Pan Yan, Zhang Xiaolin. Correlation between serum lipoprotein-associated phospholipase A2 level and the severity and prognosis of acute ischemic stroke [J]. Clinical Focus, 2023, 38(4): 315-318.
[6]	Jia Yangjuan, Han Ning, Guo Hui, Li Yanpeng, Li Cancan, Li Jianguo. Value of Mini Mental State Examination and Montreal Cognitive Assessment in screening mild vascular cognitive impairment at post-stroke [J]. Clinical Focus, 2023, 38(3): 221-226.
[7]	Yao Meifen, Ding Gangyu, Xu Jianhua, Wang Guojiang. Efficacy and safety of recombinant tissue plasminogen activator in patients with acute mild ischemic stroke [J]. Clinical Focus, 2023, 38(3): 227-231.
[8]	Jia Yangjuan, Han Ning, Guo Hui, Li Cancan, Li Jianguo. Value of different clock drawing tests in identifying acute post-stroke cognitive impairment no dementia [J]. Clinical Focus, 2023, 38(2): 143-148.
[9]	Zhang Fang, Zhang Yichao, Jia Xinwei, Li Jianlong, Chen Chunhong. Analysis of one-year follow-up results of ≥75-year-old atrial fibrillation inpatients with high CHA2DS2-VASc score [J]. Clinical Focus, 2023, 38(2): 117-120.
[10]	Ma Hongli, Lu Hao, Wang Dan, Jiao Haixing, Li Yike, Li Siyu, Lu Jing. Meta-analysis of disability risk factors in stroke patients [J]. Clinical Focus, 2023, 38(2): 111-116.
[11]	Li Lisha, Shen Xianghui, Liu Yanhui, Ren Yanbin. Aortic root anatomy and atrial septal mobility analyzed by transesophageal echocardiography [J]. Clinical Focus, 2023, 38(11): 1012-1015.
[12]	Yu Yifu, Yuan Chunhua. Research on the effects of diaphragm relaxation technique combined with resistance breathing training on motor ability of stroke survivors [J]. Clinical Focus, 2023, 38(11): 1002-1007.
[13]	Luo Weigang, Xu Yuzhu, Zhang Lingyan, Wu Xiangyun, Bu Wei, Ren Huiling. Predictive value of the platelet function PFA-200 P2Y on the secondary prevention of acute ischemic stroke with clopidogrel [J]. Clinical Focus, 2023, 38(11): 979-983.
[14]	Ding Siqi, Liu Shihua, Zhang Chao, Zhong Ping, Cao Li. Risk factors for epilepsy after delayed post-stroke epilepsy and its clinical correlation with blood Hcy, hs-CRP and D-D [J]. Clinical Focus, 2023, 38(10): 893-897.
[15]	Xu Wendeng, Shen Yi, Zhang Xiaofeng. Correlation between nonspecific ST-T abnormalities in electrocardiogram and recurrence of acute ischemic stroke [J]. Clinical Focus, 2023, 38(10): 883-886.